Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijesh Kumar

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Biomolecules|July 28, 2019
Antrodia cinnamomea Enhances Chemo-Sensitivity of 5-FU and Suppresses Colon Tumorigenesis and Cancer Stemness via Up-Regulation of Tumor Suppressor miR-142-3pYan-Jiun Huang, Vijesh Kumar Yadav, Prateeti Srivastava, et al.
Translational Oncology|January 17, 2025
Targeting FABP4/UCP2 axis to overcome cetuximab resistance in obesity-driven CRC with drug-tolerant persister cellsYi-Chiao Cheng, Ming-Yao Chen, Vijesh Kumar Yadav, et al.
International Journal of Molecular Sciences|June 2, 2021
In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1Harshita Nivrutti Khedkar, Yu-Chi Wang, Vijesh Kumar Yadav, et al.
Cancers|December 28, 2019
Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival FibroblastsJia-Hong Chen, Alexander T H Wu, Oluwaseun Adebayo Bamodu, et al.
Translational Oncology|October 30, 2025
Drug-tolerant persister cells in head and neck squamous cell carcinoma: Molecular mechanisms and therapeutic opportunitiesHang Huong Ling, Huei-Yu Huang, Chih-Ming Huang, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Lipoprotein(a)/CD36 Interaction Drives IL-6/RhoA-GTP Signaling and miRNA Epigenetic Regulation in Coronary Artery SpasmYen-Kuang Lin, Tsung-Han Hsieh, Chi-Tai Yeh, et al.
Cancers|December 10, 2021
The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer CellsWen-Chien Huang, Vijesh Kumar Yadav, Wei-Hong Cheng, et al.
Journal of Hazardous Materials|December 20, 2024
Co-resistance is the dominant mechanism of co-selection and dissemination of antibiotic resistome in nano zinc oxide polluted soilR Dinesh, C P Sreena, T E Sheeja, et al.
Cancers|July 2, 2021
Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 AxisMing-Yao Chen, Vijesh Kumar Yadav, Yi Cheng Chu, et al.
Biomedicines|July 27, 2022
Ubiquitin-Specific Protease 6 n-Terminal-like Protein (USP6NL) and the Epidermal Growth Factor Receptor (EGFR) Signaling Axis Regulates Ubiquitin-Mediated DNA Repair and Temozolomide-Resistance in GlioblastomaI-Chang Su, Yu-Kai Su, Hao-Yu Chuang, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Biomolecules|July 28, 2019
Antrodia cinnamomea Enhances Chemo-Sensitivity of 5-FU and Suppresses Colon Tumorigenesis and Cancer Stemness via Up-Regulation of Tumor Suppressor miR-142-3pYan-Jiun Huang, Vijesh Kumar Yadav, Prateeti Srivastava, et al.
Translational Oncology|January 17, 2025
Targeting FABP4/UCP2 axis to overcome cetuximab resistance in obesity-driven CRC with drug-tolerant persister cellsYi-Chiao Cheng, Ming-Yao Chen, Vijesh Kumar Yadav, et al.
International Journal of Molecular Sciences|June 2, 2021
In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1Harshita Nivrutti Khedkar, Yu-Chi Wang, Vijesh Kumar Yadav, et al.
Cancers|December 28, 2019
Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival FibroblastsJia-Hong Chen, Alexander T H Wu, Oluwaseun Adebayo Bamodu, et al.
Translational Oncology|October 30, 2025
Drug-tolerant persister cells in head and neck squamous cell carcinoma: Molecular mechanisms and therapeutic opportunitiesHang Huong Ling, Huei-Yu Huang, Chih-Ming Huang, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Lipoprotein(a)/CD36 Interaction Drives IL-6/RhoA-GTP Signaling and miRNA Epigenetic Regulation in Coronary Artery SpasmYen-Kuang Lin, Tsung-Han Hsieh, Chi-Tai Yeh, et al.
Cancers|December 10, 2021
The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer CellsWen-Chien Huang, Vijesh Kumar Yadav, Wei-Hong Cheng, et al.
Journal of Hazardous Materials|December 20, 2024
Co-resistance is the dominant mechanism of co-selection and dissemination of antibiotic resistome in nano zinc oxide polluted soilR Dinesh, C P Sreena, T E Sheeja, et al.
Cancers|July 2, 2021
Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 AxisMing-Yao Chen, Vijesh Kumar Yadav, Yi Cheng Chu, et al.
Biomedicines|July 27, 2022
Ubiquitin-Specific Protease 6 n-Terminal-like Protein (USP6NL) and the Epidermal Growth Factor Receptor (EGFR) Signaling Axis Regulates Ubiquitin-Mediated DNA Repair and Temozolomide-Resistance in GlioblastomaI-Chang Su, Yu-Kai Su, Hao-Yu Chuang, et al.
Pageof 9